After-Hours Stock Movers 02/28: (DDD) (ACI) (WDAY) Higher; (GDRX) (AMBA) (LCID) Lower (more...)

Go back to After-Hours Stock Movers 02/28: (DDD) (ACI) (WDAY) Higher; (GDRX) (AMBA) (LCID) Lower (more...)

Ambarella (AMBA) PT Lowered to $200 at Rosenblatt

March 1, 2022 7:20 AM EST

Rosenblatt analyst Kevin Cassidy lowered the price target on Ambarella (NASDAQ: AMBA) to $200.00 (from $250.00) while maintaining a Buy rating.

The analyst commented, "Ambarella delivered an in-line quarter and a very slight miss to the April quarter estimates. Multiple supply chain issues that are... More

GoodRx Holdings Inc. (GDRX) PT Lowered to $30 at Goldman Sachs

March 1, 2022 6:58 AM EST

Goldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $30.00 (from $43.00) while maintaining a Buy rating following results.

The analyst commented, "We reiterate our Buy rating but lower our PT from $43 to $30 to reflect both lowered operating... More

BigCommerce Holdings (BIGC) PT Lowered to $50 at Stifel

March 1, 2022 6:53 AM EST

Stifel analyst J. Parker Lane lowered the price target on BigCommerce Holdings (NASDAQ: BIGC) to $50.00 (from $60.00) while maintaining a Buy rating.

The analyst commented, "BigCommerce closed out FY21 by beating expectations across all key revenue and supplemental metrics, including increased traction in mid-market and... More

Ambarella (AMBA) PT Lowered to $190 at Stifel

March 1, 2022 6:22 AM EST

Stifel analyst Tore Svanberg lowered the price target on Ambarella (NASDAQ: AMBA) to $190.00 (from $230.00) while maintaining a Buy rating following results. The analyst cited:

Line Jan Q Revs, w/ +$0.04 non-GAAP (NG) EPS beat on higher NG GMs.... More

GoodRx Holdings Inc. (GDRX) PT Lowered to $20 at JPMorgan

March 1, 2022 4:58 AM EST

JPMorgan analyst Doug Anmuth lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $20.00 (from $33.00) while maintaining a Underweight rating.

The analyst comments "GoodRx is focused on building the top consumer-focused digital healthcare platform in the US. Its core offering tracks... More